デフォルト表紙
市場調査レポート
商品コード
1322222

オートインジェクター市場:世界の業界分析、規模、シェア、成長、動向、予測、2023年~2031年

Autoinjectors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 189 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
オートインジェクター市場:世界の業界分析、規模、シェア、成長、動向、予測、2023年~2031年
出版日: 2023年06月07日
発行: Transparency Market Research
ページ情報: 英文 189 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オートインジェクター市場- レポートの範囲

世界のオートインジェクター市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とみなし、2017年から2031年の期間の世界のオートインジェクター市場の収益を提供します。レポートは、2023年から2031年までの世界のオートインジェクター市場の複合年間成長率(CAGR %)も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、オートインジェクター市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のオートインジェクター市場の競合情勢を詳しく掘り下げています。世界のオートインジェクター市場で活動している主要プレーヤーが特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のオートインジェクター市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017~2031年

第5章 重要な洞察

  • 技術の進歩
  • 病気の発生率と有病率
  • 概要
  • 規制分析
  • COVID-19の影響分析

第6章 世界市場の分析と予測:タイプ別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測:タイプ別、2017~2031年
    • 使い捨て
    • 再利用可能
  • 市場魅力分析:タイプ別

第7章 世界市場の分析と予測:技術別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測:技術別、2017~2031年
    • ハンドヘルド
    • ウェアラブル
  • 市場魅力分析:技術別

第8章 世界市場の分析と予測:投与経路別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測:投与経路別、2017~2031年
    • 皮下
    • 筋肉内
  • 市場魅力分析:投与経路別

第9章 世界市場の分析と予測:適応症別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測:適応症別、2017~2031年
    • 多発性硬化症
    • 関節リウマチ
    • 糖尿病
    • アナフィラキシー
    • その他
  • 市場魅力分析:適応症別

第10章 世界市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測:エンドユーザー別、2017~2031年
    • 在宅医療
    • 病院・クリニック
  • 市場魅力分析:エンドユーザー別

第11章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第12章 北米市場の分析と予測

第13章 欧州市場の分析と予測

第14章 アジア太平洋市場の分析と予測

第15章 ラテンアメリカ市場の分析と予測

第16章 中東・アフリカ市場の分析と予測

第17章 競合情勢

  • 市場プレーヤー-競合マトリックス(企業の階層および規模別)
  • 企業別の市場シェア分析(2022年)
  • 企業プロファイル
    • Ypsomed Holding AG
    • Novartis AG
    • BD
    • Medmix Healthcare
    • Eli Lilly and Company
    • Sanofi
    • Mylan NV
    • Amgen Inc.
    • SHL Medical AG
    • Recipharm AB
図表

List of Tables

  • Table 01: Global Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 04: Global Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 05: Global Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Autoinjectors Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Autoinjectors Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 09: North America Autoinjectors Market (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 11: North America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 12: North America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 17: Europe Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 18: Europe Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 21: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 22: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 23: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 24: Asia Pacific Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 27: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Technology 2017-2031
  • Table 28: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 29: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Latin America Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 33: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 34: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 35: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 36: Middle East and Africa Autoinjectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Autoinjectors Market Value Share, by Type, 2022
  • Figure 03: Global Autoinjectors Market Value Share, by Technology, 2022
  • Figure 04: Global Autoinjectors Market Value Share, by Indication, 2022
  • Figure 05: Global Autoinjectors Market Value Share, by Route of Administration, 2022
  • Figure 06: Global Autoinjectors Market Value Share, by End-user, 2022
  • Figure 07: Global Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 08: Global Autoinjectors Market Revenue (US$ Mn), by Disposable, 2017-2031
  • Figure 09: Global Autoinjectors Market Revenue (US$ Mn), by Reusable, 2017-2031
  • Figure 10: Global Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 11: Global Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 12: Global Autoinjectors Market Revenue (US$ Mn), by Handheld, 2017-2031
  • Figure 13: Global Autoinjectors Market Revenue (US$ Mn), by Wearable, 2017-2031
  • Figure 14: Global Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 15: Global Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 16: Global Autoinjectors Market Revenue (US$ Mn), by Subcutaneous, 2017-2031
  • Figure 17: Global Autoinjectors Market Revenue (US$ Mn), by Intramuscular, 2017-2031
  • Figure 18: Global Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 19: Global Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 20: Global Autoinjectors Market Revenue (US$ Mn), by Multiple Sclerosis, 2017-2031
  • Figure 21: Global Autoinjectors Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2017-2031
  • Figure 22: Global Autoinjectors Market Revenue (US$ Mn), by Diabetes, 2017-2031
  • Figure 23: Global Autoinjectors Market Revenue (US$ Mn), by Anaphylaxsis, 2017-2031
  • Figure 24: Global Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 25: Global Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: Global Autoinjectors Market Value Share Analysis, by Homecare Settings, 2022 and 2031
  • Figure 27: Global Autoinjectors Market Value Share Analysis, by Hospitals & Clinics, 2022 and 2031
  • Figure 28: Global Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 29: North America Autoinjectors Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 30: North America Autoinjectors Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 31: North America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 32: North America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 33: North America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 34: North America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 35: North America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 36: North America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 37: North America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 38: North America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 39: North America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Europe Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 43: Europe Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Europe Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 45: Europe Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 46: Europe Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 47: Europe Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 48: Europe Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Europe Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 50: Europe Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 51: Europe Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 52: Europe Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 53: Europe Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Asia Pacific Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 55: Asia Pacific Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 56: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Asia Pacific Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 58: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 59: Asia Pacific Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 60: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 61: Asia Pacific Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 62: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 63: Asia Pacific Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 64: Asia Pacific Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 65: Asia Pacific Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 66: Asia Pacific Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 67: Latin America Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 68: Latin America Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Latin America Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 70: Latin America Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 71: Latin America Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 72: Latin America Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 73: Latin America Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 74: Latin America Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 75: Latin America Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 76: Latin America Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 77: Latin America Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 78: Latin America Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Latin America Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Middle East and Africa Autoinjectors Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 81: Middle East and Africa Autoinjectors Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 82: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 83: Middle East and Africa Autoinjectors Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 84: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 85: Middle East and Africa Autoinjectors Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 86: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 87: Middle East and Africa Autoinjectors Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 88: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 89: Middle East and Africa Autoinjectors Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 90: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 91: Middle East and Africa Autoinjectors Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 92: Middle East and Africa Autoinjectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 93: Company Share Analysis, 2022
目次
Product Code: TMRGL85651

Autoinjectors Market - Scope of Report

TMR's report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Autoinjectors Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Autoinjectors Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Autoinjectors Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Autoinjectors Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Autoinjectors Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Autoinjectors Market.

The report delves into the competitive landscape of the global Autoinjectors Market. Key players operating in the global Autoinjectors Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Autoinjectors Market profiled in this report.

Key Questions Answered in Global Autoinjectors Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Autoinjectors Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Autoinjectors Market - Research Objectives and Research Approach

The comprehensive report on the global Autoinjectors Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Autoinjectors Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Autoinjectors.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Autoinjectors Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Autoinjectors Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Disease Incidence and Prevalence
  • 5.3. Overview: Future of Autoinjectors
  • 5.4. Regulatory Analysis
  • 5.5. COVID-19 Impact Analysis

6. Global Autoinjectors Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Disposable
    • 6.3.2. Reusable
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Autoinjectors Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Handheld
    • 7.3.2. Wearable
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Autoinjectors Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 8.3.1. Subcutaneous
    • 8.3.2. Intramuscular
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Autoinjectors Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Multiple Sclerosis
    • 9.3.2. Rheumatoid Arthritis
    • 9.3.3. Diabetes
    • 9.3.4. Anaphylaxsis
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Autoinjectors Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Homecare Settings
    • 10.3.2. Hospitals & Clinics
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Autoinjectors Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Autoinjectors Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Disposable
    • 12.2.2. Reusable
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. Handheld
    • 12.3.2. Wearable
  • 12.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.4.1. Subcutaneous
    • 12.4.2. Intramuscular
  • 12.5. Market Value Forecast, by Indication, 2017-2031
    • 12.5.1. Multiple Sclerosis
    • 12.5.2. Rheumatoid Arthritis
    • 12.5.3. Diabetes
    • 12.5.4. Anaphylaxsis
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by End-user, 2017-2031
    • 12.6.1. Homecare Settings
    • 12.6.2. Hospitals & Clinics
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Technology
    • 12.8.3. By Route of Administration
    • 12.8.4. By Indication
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Autoinjectors Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Disposable
    • 13.2.2. Reusable
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. Handheld
    • 13.3.2. Wearable
  • 13.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.4.1. Subcutaneous
    • 13.4.2. Intramuscular
  • 13.5. Market Value Forecast, by Indication, 2017-2031
    • 13.5.1. Multiple Sclerosis
    • 13.5.2. Rheumatoid Arthritis
    • 13.5.3. Diabetes
    • 13.5.4. Anaphylaxsis
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by End-user, 2017-2031
    • 13.6.1. Homecare Settings
    • 13.6.2. Hospitals & Clinics
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Technology
    • 13.8.3. By Route of Administration
    • 13.8.4. By Indication
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Autoinjectors Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Disposable
    • 14.2.2. Reusable
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. Handheld
    • 14.3.2. Wearable
  • 14.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.4.1. Subcutaneous
    • 14.4.2. Intramuscular
  • 14.5. Market Value Forecast, by Indication, 2017-2031
    • 14.5.1. Multiple Sclerosis
    • 14.5.2. Rheumatoid Arthritis
    • 14.5.3. Diabetes
    • 14.5.4. Anaphylaxsis
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by End-user, 2017-2031
    • 14.6.1. Homecare Settings
    • 14.6.2. Hospitals & Clinics
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Route of Administration
    • 14.8.3. By Technology
    • 14.8.4. By Indication
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Autoinjectors Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2017-2031
    • 15.2.1. Disposable
    • 15.2.2. Reusable
  • 15.3. Market Value Forecast, by Technology, 2017-2031
    • 15.3.1. Handheld
    • 15.3.2. Wearable
  • 15.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.4.1. Subcutaneous
    • 15.4.2. Intramuscular
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Multiple Sclerosis
    • 15.5.2. Rheumatoid Arthritis
    • 15.5.3. Diabetes
    • 15.5.4. Anaphylaxsis
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by End-user, 2017-2031
    • 15.6.1. Homecare Settings
    • 15.6.2. Hospitals & Clinics
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Technology
    • 15.8.3. By Route of Administration
    • 15.8.4. By Indication
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Autoinjectors Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2017-2031
    • 16.2.1. Disposable
    • 16.2.2. Reusable
  • 16.3. Market Value Forecast, by Technology, 2017-2031
    • 16.3.1. Handheld
    • 16.3.2. Wearable
  • 16.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 16.4.1. Subcutaneous
    • 16.4.2. Intramuscular
  • 16.5. Market Value Forecast, by Indication, 2017-2031
    • 16.5.1. Multiple Sclerosis
    • 16.5.2. Rheumatoid Arthritis
    • 16.5.3. Diabetes
    • 16.5.4. Anaphylaxsis
    • 16.5.5. Others
  • 16.6. Market Value Forecast, by End-user, 2017-2031
    • 16.6.1. Homecare Settings
    • 16.6.2. Hospitals & Clinics
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Technology
    • 16.8.3. By Route of Administration
    • 16.8.4. By Indication
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Ypsomed Holding AG
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Novartis AG
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.4. Recent Developments
    • 17.3.3. BD
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Medmix Healthcare
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Eli Lilly and Company
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Sanofi
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Mylan N.V.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Amgen Inc.
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. SHL Medical AG
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Recipharm AB
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments